Mastodynia. Mastodynia
Conditions
Interventions
Intervention 1: In main group, patients with moderate to severe pain of breast enter to the study. Chamomile were used 5 drops, 3 times a day for two cycle since the beginning to the end of the menstr
Treatment - Drugs
Placebo
In main group, patients with moderate to severe pain of breast enter to the study. Chamomile were used 5 drops, 3 times a day for two cycle since the beginning to the end of the menstrual cycle. At th
In intervention group, patients with moderate to severe pain of breast enter to the study. Pelacebo were used 5 drops, 3 times a day for two cycle since the beginning to the end of the menstrual cycle
Sponsors
Deputy for Research Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged 18 to 45 years? pain of breast stsrted 2 weeks before menstruation and pain reduced with menstruation? approximate regular menstrual periods in recent 3 rounds Exclusion criteria: Underlying disease of uterin? breast and hormonal? pregnancy? lactating and menopause? using sex steroids? Danazol? oil of evening primrose? vitamin B6? NSAIDs? Bromocriptine? Selective Estrogen Receptor Inhibitors? regular use of Aspirin or other trearments to reduce pain of breast over the past two months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mastalgia. Timepoint: Before and after the intervention. Method of measurement: Using Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity to placebo or camomile. Timepoint: Before and after intervention. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasumeh Ghazanfarpour
Mashhad University of Medical Sciences
Outcome results
None listed